Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Roux-en-Y gastric bypass and biliopancreatic diversion can markedly ameliorate diabetes in morbidly obese patients, often resulting in disease remission. Prospective, randomized trials comparing these procedures with medical therapy for the treatment of diabetes are needed. METHODS: In this single-center, nonblinded, randomized, controlled trial, 60 patients between the ages of 30 and 60 years with a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 35 or more, a history of at least 5 years of diabetes, and a glycated hemoglobin level of 7.0% or more were randomly assigned to receive conventional medical therapy or undergo either gastric bypass or biliopancreatic diversion. The primary end point was the rate of diabetes remission at 2 years (defined as a fasting glucose level of <100 mg per deciliter [5.6 mmol per liter] and a glycated hemoglobin level of <6.5% in the absence of pharmacologic therapy). RESULTS: At 2 years, diabetes remission had occurred in no patients in the medical-therapy group versus 75% in the gastric-bypass group and 95% in the biliopancreatic-diversion group (P<0.001 for both comparisons). Age, sex, baseline BMI, duration of diabetes, and weight changes were not significant predictors of diabetes remission at 2 years or of improvement in glycemia at 1 and 3 months. At 2 years, the average baseline glycated hemoglobin level (8.65±1.45%) had decreased in all groups, but patients in the two surgical groups had the greatest degree of improvement (average glycated hemoglobin levels, 7.69±0.57% in the medical-therapy group, 6.35±1.42% in the gastric-bypass group, and 4.95±0.49% in the biliopancreatic-diversion group). CONCLUSIONS: In severely obese patients with type 2 diabetes, bariatric surgery resulted in better glucose control than did medical therapy. Preoperative BMI and weight loss did not predict the improvement in hyperglycemia after these procedures. (Funded by Catholic University of Rome; ClinicalTrials.gov number, NCT00888836.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A total of 8 articles were used across more than 1 component.141,142,144,148,156,159,168,169”
In the citing paper
“The complication evidence base included those studies from the efficacy and predictors searches that included complication data,141,156 as well as those studies that met the expanded search criteria.139,143,145,146,152,153,160,170,171”
In the citing paper
“A total of 10 studies (12 articles) met the inclusion criteria, were rated as good or fair quality, and are included in the summary table.141,142,144,148,151,155,156,159,161,168,169,172”
In the citing paper
“Fifteen RCTs were identified comparing weight loss after bariatric surgery or medical therapy (5 reporting on RYGB, 3 on LAGB and the rest on mixed patient populations undergoing sleeve gastrectomy, BPD/DS, sleeve gastrectomy and/or banding) [21–35].”
In the citing paper
“EWL was similar (WMD 14%, 95% CI − 12.21 to 42.15, very low certainty), whereas long-term morbidity (OR 3.38, 95% CI 1.14 to 10.05, low certainty) and diabetes remission (OR 8.06, 95% CI 1.35 to 48.14) were in favor of RYGB (Supplementary Table S21).”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Meta-Analysis: Surgical Treatment of Obesity
Maggard, M. A., Shugarman, L. R., Suttorp, M., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W. A., Hilton, L., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
How do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003
Self-citationRubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G., Castagneto, M., & Marescaux, J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000224726.61448.1b · Cited by 928
Self-citationLaferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682
Cited by
Items 401–500 of 1,003
Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass
Gastaldelli, A., Iaconelli, A., Gaggini, M., Magnone, M. C., Veneziani, A., Rubino, F., & Mingrone, G. (2016) · Diabetes Care · doi:10.2337/dc15-2823 · Cited by 46
Self-citationHolter, M. M., Dutia, R., Stano, S., Prigeon, R. L., Homel, P., McGinty, J. J., Belsley, S., Ren, C. J., Rosen, D., & Laferrère, B. (2016) · Diabetes Care · doi:10.2337/dc16-1376 · Cited by 46
Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass
Harris, L.-A., Kayser, B. D., Cefalo, C., Marini, L., Watrous, J. D., Ding, J., Jain, M., McDonald, J. G., Thompson, B. M., Fabbrini, E., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.002 · Cited by 44
“(Mingrone et al., 2012; Panunzi et al., 2016), suggesting that weight loss-independent effects of BPD contribute to its therapeutic efficacy.”
BackgroundMethodInfluentialSelf-citationChen, G., Zhang, G., Peng, B.-Q., Cheng, Z., & Du, X. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05456-0 · Cited by 48
Balasubaramaniam, V., & Pouwels, S. (2023) · Medicina · doi:10.3390/medicina59050985 · Cited by 62
“Though bariatric surgery was traditionally intended as a treatment for weight loss, it has demonstrated major effects on reducing rates of T2DM, improving cardiovascular health and, in turn, reducing morbidity and mortality [8].”
BackgroundCardiovascular benefits of bariatric surgery
Lee, G. K., & Cha, Y. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.07.006 · Cited by 57
Fischer, L., Nickel, F., Sander, J., Ernst, A., Bruckner, T. M., Herbig, B., Büchler, M. W., Müller-Stich, B. P., & Sandbu, R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.02.040 · Cited by 50
Heo, Y., Park, J., Kim, Y.-J., Kim, S.-M., Park, D. J., Lee, S. K., Han, S.-M., Shim, K.-W., Lee, Y.-J., Lee, J.-Y., et al. (2012) · Journal of the Korean Surgical Society · doi:10.4174/jkss.2012.83.6.335 · Cited by 44
Should metabolic surgery be offered in morbidly obese patients with type I diabetes?
Robert, M., Belanger, P., Hould, F., Marceau, S., Tchernof, A., & Biertho, L. D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.016 · Cited by 44
Assessment of glucose regulation in pregnancy after gastric bypass surgery
Göbl, C. S., Bozkurt, L., Tura, A., Leutner, M., Andrei, L., Fahr, L., Husslein, P. W., Eppel, W., & Kautzky‐Willer, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4437-6 · Cited by 46
Zhai, H., Li, Z., Peng, M., Huang, Z., Qin, T., Chen, L., Li, H., Zhang, H., Zhang, W., & Xu, G. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.026 · Cited by 47
“Roux-en-Y gastric bypass (RYGB) is themost effective approach for weight loss and randomized, controlled trials demonstrate its superiority compared to medical therapy for diabetes control [2,3].”
BackgroundMartin, W. P., Docherty, N. G., & le Roux, C. W. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1518130 · Cited by 49
“Mingrone et al’s RCT compared with CROSSROADS [15, 16, 17].”
BackgroundResultBoerboom, A. B., Homan, J., Aarts, E. O., Aufenacker, T. J., Janssen, I. M. C., & Berends, F. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.10.010 · Cited by 46
Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
Ryan, D. H., & Bray, G. A. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0343-6 · Cited by 45
Changes in adipokine levels and metabolic profiles following bariatric surgery
Šebunova, N., Štšepetova, J., Kullisaar, T., Suija, K., Rätsep, A., Junkin, I., Soeorg, H., Lember, M., Sillakivi, T., & Mändar, R. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00942-7 · Cited by 48
Socioeconomic disparities and bariatric surgery outcomes: A qualitative analysis
Funk, L. M., Alagöz, E., Murtha, J. A., Breuer, C. R., Pati, B., Eierman, L., Jawara, D., Farrar‐Edwards, D., & Voils, C. I. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.09.049 · Cited by 44
Rubino, F. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0369-x · Cited by 54
Self-citationSurgery in the treatment of type 2 diabetes mellitus
Maleckas, A., Venclauskas, L., Wallenius, V., Lönroth, H., & Fändriks, L. (2015) · Scandinavian Journal of Surgery · doi:10.1177/1457496914561140 · Cited by 48
Bariatric Surgery for Patients With Early-Onset vs Late-Onset Type 2 Diabetes
Aung, L., Lee, W.-J., Chen, S. C., Ser, K.-H., Wu, C.-C., Chong, K., Lee, Y.-C., & Chen, J.-C. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.1130 · Cited by 37
Laparoscopic Roux-en-Y Gastric Bypass
Berbiglia, L., Zografakis, J. G., & Dan, A. G. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.003 · Cited by 49
Khorgami, Z., Haskins, I. N., Aminian, A., Andalib, A., Rosen, M. J., Brethauer, S. A., & Schauer, P. R. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.01.007 · Cited by 46
Metabolic Effects of Bariatric Surgery
Sinclair, P., Docherty, N. G., & le Roux, C. W. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.272336 · Cited by 52
Ahuja, A., Tantia, O., Chaudhuri, T., Khanna, S., Seetharamaiah, S., Majumdar, K., & Goyal, G. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3136-9 · Cited by 42
Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study
Johansson, K., Svensson, P., Söderling, J. K., Peltonen, M., Neovius, M., Carlsson, L. M. S., & Sjöholm, K. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00141-8 · Cited by 48
Cardiovascular and Renal Effects of Weight Reduction in Obesity and the Metabolic Syndrome
Cohen, J. B., & Cohen, D. L. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0544-2 · Cited by 42
Cohen, R. V., Pereira, T. V., Aboud, C. M., Zanata Petry, T. B., Lopes Correa, J. L., Schiavon, C. A., Pompílio, C. E., Quirino Pechy, F. N., Calmon da Costa Silva, A. C., Cunha da Silveira, L. P., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101725 · Cited by 41
Weight Loss Prediction after Metabolic and Bariatric Surgery
Park, J. Y. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23008 · Cited by 54
Marceau, P., Biron, S., Marceau, S., Hould, F., Lebel, S., Lescelleur, O., Biertho, L. D., & Kral, J. G. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1284-0 · Cited by 49
Thereaux, J., Veyrie, N., Barsamian, C., Corigliano, N., Beauchet, A., Poitou, C., Oppert, J., Czernichow, S., & Bouillot, J. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.625 · Cited by 44
Elbanna, H. G., Ghnnam, W., Negm, A. M., Youssef, T., Emile, S. H., Metwally, T. A. E., & Elalfy, K. (2016) · Turkish Journal of Surgery · doi:10.5152/ucd.2016.3275 · Cited by 51
Pharmacological management of obesity an endocrine society clinical practice guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.23.59-63 · Cited by 41
Huang, H., Lee, W., Chen, S., Chen, T.-F., Lee, S., & Chen, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060815 · Cited by 43
“SG, a bariatric surgery, is currently considered one of the effective treatments for patients with morbid obesity (body mass index (BMI), > 35 kg/m2) [15] and Asian patients with non-morbid obesity (BMI, < 35 kg/m2) and not-well-controlled T2DM [16].”
BackgroundSingh, P., Adderley, N. J., Hazlehurst, J., Price, M. J., Tahrani, A. A., Nirantharakumar, K., & Bellary, S. (2021) · Diabetes Care · doi:10.2337/dc21-0166 · Cited by 50
Li, D., Jia, L., Wu, X.-L., & Cheng, M. Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s508365 · Cited by 69
Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery
Salehi, M., & D’Alessio, D. A. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9291-y · Cited by 40
Bariatric and metabolic outcomes in the super-obese elderly
Daigle, C. R., Andalib, A., Corcelles, R., Cetin, D. C., Schauer, P. R., & Brethauer, S. A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.04.006 · Cited by 41
What is the Mechanism Behind Weight Loss Maintenance with Gastric Bypass?
Chakravartty, S., Tassinari, D., Salerno, A., Giorgakis, E., & Rubino, F. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0158-7 · Cited by 45
Self-citationKenngott, H. G., Clemens, G., Gondan, M., Senft, J., Diener, M. K., Rudofsky, G., Nawroth, P. P., Büchler, M. W., Fischer, L., & Müller-Stich, B. P. (2013) · Trials · doi:10.1186/1745-6215-14-183 · Cited by 40
Salinari, S., Carr, R. D., Guidone, C., BERTUZZI, A., Cercone, S., Riccioni, M. E., Manto, A., Ghirlanda, G., & Mingrone, G. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00559.2012 · Cited by 42
Self-citationWolf, R. M., Jaffe, A. E., Steele, K. E., Schweitzer, M., Magnuson, T. H., Wolfe, A., & Wong, G. W. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02245 · Cited by 43
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Debédat, J., Amouyal, C., Aron‐Wisnewsky, J., & Clément, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00738-3 · Cited by 48
Chen, G. (2021) · Cells · doi:10.3390/cells10082160 · Cited by 49
Shikora, S. A., Toouli, J., Herrera, M. F., Kulseng, B. E., Brancatisano, R., Kow, L., Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., et al. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1914-1 · Cited by 41
Metabolic and Bariatric Surgery for Obesity
Vidal, J., Corcelles, R., Jiménez, A., Flores, L., & Lacy, A. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.051 · Cited by 45
Abu-Elmagd, K. M., Costa, G., McMichael, D., Khanna, A., CRUZ, R. J., Jr., Parekh, N. R., Fujiki, M., Hashimoto, K., Quintini, C., Darlene, A., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001440 · Cited by 40
Wood, G. C., Horwitz, D., Still, C. D., Mirshahi, T., Benotti, P. N., Parikh, M., & Hirsch, A. G. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2799-y · Cited by 37
Do Food Preferences Change After Bariatric Surgery?
Gerö, D., Steinert, R. E., le Roux, C. W., & Bueter, M. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0674-x · Cited by 47
Combination phentermine and topiramate extended release in the management of obesity.
Alfaris, N., Minnick, A. M., Hopkins, C. M., Berkowitz, R. I., & Wadden, T. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1041505 · Cited by 38
Zhou, X., & Zeng, C. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01283-9 · Cited by 50
Why do we need drugs to treat the patient with obesity?
Bray, G. A. (2013) · Obesity · doi:10.1002/oby.20394 · Cited by 38
Bariatric Surgery for Metabolic Syndrome in Obesity
Shuai, X., Tao, K., Mori, M., & Kanda, T. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0115 · Cited by 38
Wahlstrom, A. M., Aydin, Ö., Olsson, L. M., Sjöland, W., Henricsson, M., Lundqvist, A., Marschall, H., Franken, R. J., van de Laar, A. W. J. M., Gerdes, V. E. A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105265 · Cited by 39
Deitel, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16245-9_1 · Cited by 37
Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health
Miras, A. D., & le Roux, C. W. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70158-x · Cited by 40
Is the Gut the “Sweet Spot” for the Treatment of Diabetes?
Rubino, F., & Amiel, S. A. (2014) · Diabetes · doi:10.2337/db14-0402 · Cited by 41
Self-citationLaparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Type 2 Diabetes Mellitus
Seki, Y., Kasama, K., Umezawa, A., & Kurokawa, Y. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2057-8 · Cited by 36
Shah, K., Nergård, B.-J., Frazier, K. S., Leifsson, B. G., Aghajani, E., & Gíslason, H. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.03.017 · Cited by 39
Campbell, L. E., Langlais, P. R., Day, S. E., Coletta, R. L., Benjamin, T. R., Filippis, E. A. D., Madura, J. A., Mandarino, L. J., Roust, L. R., & Coletta, D. K. (2016) · Diabetes · doi:10.2337/db16-0004 · Cited by 40
Skuratovskaia, D., Litvinova, L. S., Vulf, M. A., Затолокин, П. А., Popadin, K. Y., & Mazunin, I. (2019) · Cells · doi:10.3390/cells8050430 · Cited by 41
“Thus, in patients after surgical treatment, the BMI decreases, however, according to literature data, restoration of insulin sensitivity precedes a significant change in the mass of adipose tissue [18].”
BackgroundThe role of total alimentary limb length in Roux-en-Y gastric bypass: a systematic review
Wang, A., Poliakin, L., Sundaresan, N., Vijayanagar, V., Abdurakhmanov, A., Thompson, K. J., McKillop, I. H., Barbat, S. D., Bauman, R. W., Gersin, K. S., et al. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.08.022 · Cited by 39
“Roux-en-Y gastric bypass surgery (RYGB) is established as an effective weight loss and co-morbidity resolution strategy that is superior to medical management alone [1,2].”
BackgroundBowels control brain: gut hormones and obesity
Bewick, G. A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.032 · Cited by 36
Kamocka, A., Chidambaram, S., Erridge, S., Vithlani, G., Miras, A. D., & Purkayastha, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01186-0 · Cited by 40
Angelini, G., Castagneto‐Gissey, L., Salinari, S., BERTUZZI, A., Anello, D., Pradhan, M., Zschätzsch, M., Ritter, P., le Roux, C. W., Rubino, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35310-5 · Cited by 41
Self-citationContinued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit
Ghanem, O. M., Mosleh, K. A., Kerbage, A., Lu, L. Y., Hage, K., & Dayyeh, B. K. A. (2024) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000934 · Cited by 37
Kwon, Y., Abdemur, A., Menzo, E. L., Park, S. S., Szomstein, S., & Rosenthal, R. J. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.09.013 · Cited by 39
Di, J., Zhang, H., Yu, H., Zhang, P., Wang, Z., & Jia, W. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.007 · Cited by 37
“Several studies, including randomized controlled trials, have shown that surgery eliminates or markedly reduces the need for diabetes medications [1–3].”
BackgroundThe natural history of perforated marginal ulcers after gastric bypass surgery
Altieri, M. S., Pryor, A. D., Yang, J., Yin, D., Docimo, S., Bates, A. T., Talamini, M. A., & Spaniolas, K. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5794-4 · Cited by 36
The metabolic benefits of different bariatric operations: what procedure to choose?
Sudlow, A. C., le Roux, C. W., & Pournaras, D. J. (2020) · Endocrine Connections · doi:10.1530/ec-19-0467 · Cited by 42
Karpińska, I. A., Kulawik, J., Pisarska, M., Wysocki, M., Pędziwiatr, M., & Major, P. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05341-w · Cited by 42
Revisional Bariatric/Metabolic Surgery: What Dictates Its Indications?
Ma, P., Reddy, S., & Higa, K. D. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0592-3 · Cited by 42
Gastric Bypass: Current Results and Different Techniques
Vines, L. C., & Schiesser, M. (2014) · Digestive Surgery · doi:10.1159/000360433 · Cited by 38
Marchesini, G., Bugianesi, E., Burra, P., Marra, F., Miele, L., Alisi, A., Vajro, P., Masarone, M., Petta, S., Persico, M., et al. (2022) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.04.028 · Cited by 35
Effect of Gastric Bypass Versus Diet on Cardiovascular Risk Factors
Raffaelli, M., Guidone, C., Callari, C., Iaconelli, A., Bellantone, R. D. A., & Mingrone, G. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31829d6989 · Cited by 38
Self-citationEnglish, T. M., Malkani, S., Kinney, R. L., Omer, A., Dziewietin, M. B., & Perugini, R. A. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1339-2 · Cited by 35
Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus
Wu, G.-Z., Cai, B., Yu, F., Fang, Z., Fu, X.-L., Zhou, H.-S., Zhang, W., & Tian, Z.-Q. (2016) · Oncotarget · doi:10.18632/oncotarget.11961 · Cited by 35
Azim, S., & Kashyap, S. R. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.011 · Cited by 44
de Oliveira, V. L. P., Martins, G. P., Mottin, C. C., Rizzolli, J., & Friedman, R. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2830-3 · Cited by 39
Predictive factors for diabetes remission after bariatric surgery
Dang, J. T., Sheppard, C. E., Kim, D. S., Switzer, N. J., Shi, X., Tian, C., de Gara, C., Karmali, S., & Birch, D. W. (2019) · Canadian Journal of Surgery · doi:10.1503/cjs.014516 · Cited by 40
Prehabilitation for Bariatric Surgery: A Randomized, Controlled Trial Protocol and Pilot Study
Delgado, Y. G., López-Madrazo-Hernández, M. J., Alvarado-Martel, D., Miranda-Calderín, G., Ugarte-Lopetegui, A., González-Medina, R. A., Hernández-Lázaro, A., Zamorano, G. B. Z., Pérez-Martín, N., Sánchez-Hernández, R. M., et al. (2021) · Nutrients · doi:10.3390/nu13092903 · Cited by 39
Receptivity to Bariatric Surgery in Qualified Patients
Fung, M., Wharton, S., Macpherson, A., & Kuk, J. L. (2016) · Journal of Obesity · doi:10.1155/2016/5372190 · Cited by 37
Randomized trials and evidence in medicine: A commentary on Deaton and Cartwright
Concato, J., & Horwitz, R. I. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.04.010 · Cited by 35
Maclellan, W. C., & Johnson, J. M. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2020.12.013 · Cited by 36
Sousa, J., Sousa, H. S., Vieira, S. Q., Nunes, R., Nogueiro, J., Pereira, A. D. A., Resende, F., Costa-Pinho, A., Preto, J. R., Sousa‐Pinto, B., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14060650 · Cited by 43
Fischer, L., Wekerle, A.-L., Bruckner, T., Wegener, I., Diener, M. K., Frankenberg, M. V., Gärtner, D., Schön, M. R., Raggi, M. C., Tanay, E., et al. (2015) · BMC Surgery · doi:10.1186/s12893-015-0072-7 · Cited by 34
MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery
Corcelles, R., Daigle, C. R., & Schauer, P. R. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0533 · Cited by 37
Parikh, M., Issa, R., Vieira, D., McMacken, M., Saunders, J. K., Ude-Welcome, A., Schubart, U., Ogedegbe, G., & Pachter, L. H. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.04.023 · Cited by 34
Abegg, K., Schiesser, M., Lutz, T. A., & Bueter, M. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.03.027 · Cited by 34
Koehestanie, P., Doğan, K., Berends, F. J., Janssen, I. M. C., Wahab, P. J., Groenen, M. J. M., Müller, M. M., & de Wit, N. J. W. (2014) · Endoscopy International Open · doi:10.1055/s-0034-1365222 · Cited by 34
Arapis, K., Cavin, J., Gillard, L., Cluzeaud, F., Lettéron, P., Ducroc, R. A., Beyec, J. L., Hourseau, M., Couvelard, A., Marmuse, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121414 · Cited by 37
Brynskov, T., Laugesen, C. S., Svenningsen, A. L., Floyd, A. K., & Sørensen, T. L. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1936-8 · Cited by 34
Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes
Allen, R. E., Hughes, T. D., Ng, J. L., Ortiz, R. D., Abou-Ghantous, M., Bouhali, O., Froguel, P., & Arredouani, A. (2013) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-10-45 · Cited by 37
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study
Moriconi, D., Manca, M. L., Anselmino, M., Rebelos, E., Bellini, R., Taddei, S., Ferrannini, E., & Nannipieri, M. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101282 · Cited by 40
Verras, G., Mulita, F., Pouwels, S., Parmar, C. D., Drakos, N., Bouchagier, K., Kaplanis, C., & Skroubis, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154973 · Cited by 39
“The Swedish Obese Subjects study concluded that surgical approaches are superior in glycemic control, when compared to oral treatments, after 15 years of follow-up [41].”
BackgroundGastrointestinal Surgery for Obesity and Diabetes: Weight Loss and Control of Hyperglycemia
Heneghan, H., Nissen, S. E., & Schauer, P. R. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0285-5 · Cited by 35
Effects of bariatric surgery on cardiac remodeling: Clinical and pathophysiologic implications
Graziani, F., Leone, A. M., Cialdella, P., Basile, E., Pennestrì, F., Bona, R. D., Iaconelli, A., Liuzzo, G., Biasucci, L. M., Cardillo, M. T., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.202 · Cited by 37
Self-citationDiabetes treatment in 2025: can scientific advances keep pace with prevalence?
Shomali, M. E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812465639 · Cited by 40
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery
Raverdy, V., Tavaglione, F., Chatelain, E., Caiazzo, R. J., Saponaro, C., Lassailly, G., Verkindt, H., Baud, G., Marciniak, C., Chetboun, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155790 · Cited by 35
Clinical and adipocytokine changes after bariatric surgery in morbidly obese women
Auguet, T., Terra, X., Hernández, M., Sabench, F., Porras, J. A., Orellana‐Gavaldà, J. M., Llutart, J., Guiu‐Jurado, E., Berlanga, A., Martínez, S., et al. (2013) · Obesity · doi:10.1002/oby.20470 · Cited by 33
Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?
Cotillard, A., Poitou, C., Duchâteau-Nguyen, G., Aron‐Wisnewsky, J., Bouillot, J., Schindler, T. H., & Clément, K. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1511-8 · Cited by 34
Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus
Pok, E.-H., & Lee, W.-J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14315 · Cited by 40
Metadata
- Authors
- Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., & Rubino, F.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- NewYork–Presbyterian Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-04-26
- Volume
- 366
- Issue
- 17
- Pages
- 1577-1585
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2144631980
- Semantic Scholar
- a28bc983875a6b8fd043b1d228160f79128d4ce9
- Cited by
- 1,791
- References
- 25
- Citations by year
- 2026: 56 · 2025: 60 · 2024: 57 · 2023: 66 · 2022: 90 · 2021: 81 · 2020: 111 · 2019: 99 · 2018: 117 · 2017: 129 · 2016: 156 · 2015: 231 · 2014: 201 · 2013: 215 · 2012: 115
- FWCI
- 248.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- bariatric surgery, type 2 diabetes, Roux-en-Y gastric bypass, biliopancreatic diversion, diabetes remission, morbid obesity, HbA1c, glycemic control, medical therapy, predictors of remission
- MeSH terms
- Adult, Analysis of Variance, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Lipids, Male, Middle Aged, Obesity, Morbid, Remission Induction, Gastric Bypass, Weight Loss, Biliopancreatic Diversion, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.